Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Huvudupphovsman: | Moreino, Shannon Sherwin |
---|---|
Övriga upphovsmän: | Kabir, Eva Rahman |
Materialtyp: | Project report |
Språk: | English |
Publicerad: |
BRAC University
2018
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/9331 |
Liknande verk
-
Biologics and Biosimilars as Treatment Options for Psoriasis
av: Moya, Amena Khatun
Publicerad: (2023) -
Biosimilar in lymphoma treatment
av: Tanisha, Mehrin Haque
Publicerad: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
av: Tabassum, Turana
Publicerad: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
av: Tania, Umme
Publicerad: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
av: Tania, Umme
Publicerad: (2023)